Skip to main content

Immune DIREcted and Cancer-selective immunoTherapy

Project description

Teaching the immune system to recognise cancer tricks

Immunotherapy is a rapidly expanding field of cancer treatment that aims to ‘awaken’ the immune system to fight cancer. The aim of the EU-funded I-DireCT project is to train young researchers to develop novel ideas towards the next generation of immunotherapeutics. Researchers will receive multidisciplinary training in biomedical and physical sciences as well as in drug research and development. One of the project objectives is to generate delivery systems capable of releasing the active therapeutic only at the tumour site, thereby minimising side effects. Moreover, the project will advance existing immunotherapy antibodies and cytokines to synergistically stimulate T cell immunity against cancer.

Coordinator

ACADEMISCH ZIEKENHUIS GRONINGEN
Net EU contribution
€ 922 291,25
Address
Hanzeplein 1
9713 GZ Groningen
Netherlands

See on map

Region
Noord-Nederland Groningen Overig Groningen
Activity type
Higher or Secondary Education Establishments
Other funding
€ 922 291,25

Participants (4)

UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT
Germany
Net EU contribution
€ 379 182,60
Address
Josef-schneider-strasse 2
97080 Wurzburg

See on map

Region
Bayern Unterfranken Würzburg, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Other funding
€ 379 182,60
INOCURE SRO
Czechia
Net EU contribution
€ 469 743,12
Address
Politickych Veznu 935/13
11000 Praha

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Praha Hlavní město Praha
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 469 743,12
Surflay Nanotec GmbH
Germany
Net EU contribution
€ 505 576,80
Address
Max Planck Strasse 3
12489 Berlin

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Berlin Berlin Berlin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 505 576,80
KAHR MEDICAL LTD
Israel
Net EU contribution
€ 256 181,45
Address
1 Kiryat Hadassah, Jbp Bldg
9109701 Jerusalem

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 256 181,45